# Benefits of Combining MCT With CR in the Recovery of Patients With Psychotic Spectrum Disorders

> **NCT06423651** · NA · RECRUITING · sponsor: **Universitat Autonoma de Barcelona** · enrollment: 160 (estimated)

## Conditions studied

- Schizophrenia
- Schizophreniform Disorders
- Delusional Disorder
- Brief Psychotic Disorder
- Schizoaffective Disorder
- Schizophrenia Spectrum and Other Psychotic Disorders

## Interventions

- **BEHAVIORAL:** Cognitive Remediation (REHACOP)
- **BEHAVIORAL:** Metacognitive Training (MCT)

## Key facts

- **NCT ID:** NCT06423651
- **Lead sponsor:** Universitat Autonoma de Barcelona
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-09-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2024-05-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06423651

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06423651, "Benefits of Combining MCT With CR in the Recovery of Patients With Psychotic Spectrum Disorders". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06423651. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*